Company intelligence / Profile preview

VerGo Pharma Research Laboratories

Ownership: Private
Development stage: Commercial

Overview

Provides comprehensive CDMO/CRO services including API process development, formulation, analytical development, cGMP manufacturing, clinical trial supplies, impurity synthesis/characterization, and BA/BE studies. Successfully audited by US FDA and other global regulators. No proprietary pipeline or clinical results disclosed.

Modalities: Small moleculeGenericsSolid dosage formsClinical dose formulationsCustom synthesis
Industry: Contract Research Organization

Partnerships

Multiple global pharmaceutical companies as clients/collaborators; specific names not disclosed

Beyond the preview

Go deeper on VerGo Pharma Research Laboratories.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on VerGo Pharma Research Laboratories.

Explore the full profile